These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 33627393

  • 41. The soluble amino-terminal region of HVEM mediates efficient herpes simplex virus type 1 infection of gD receptor-negative cells.
    Baek H, Kim JH, Noh YT, Kwon H.
    Virol J; 2012 Jan 13; 9():15. PubMed ID: 22239829
    [Abstract] [Full Text] [Related]

  • 42. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity.
    Yu Z, Adusumilli PS, Eisenberg DP, Darr E, Ghossein RA, Li S, Liu S, Singh B, Shah JP, Fong Y, Wong RJ.
    Mol Ther; 2007 Jan 13; 15(1):103-13. PubMed ID: 17164781
    [Abstract] [Full Text] [Related]

  • 43. Common characteristics and unique features: A comparison of the fusion machinery of the alphaherpesviruses Pseudorabies virus and Herpes simplex virus.
    Vallbracht M, Backovic M, Klupp BG, Rey FA, Mettenleiter TC.
    Adv Virus Res; 2019 Jan 13; 104():225-281. PubMed ID: 31439150
    [Abstract] [Full Text] [Related]

  • 44. Herpes simplex virus type-1 (HSV-1) entry into human mesenchymal stem cells is heavily dependent on heparan sulfate.
    Choudhary S, Marquez M, Alencastro F, Spors F, Zhao Y, Tiwari V.
    J Biomed Biotechnol; 2011 Jan 13; 2011():264350. PubMed ID: 21799659
    [Abstract] [Full Text] [Related]

  • 45. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B.
    Satoh T, Arii J, Suenaga T, Wang J, Kogure A, Uehori J, Arase N, Shiratori I, Tanaka S, Kawaguchi Y, Spear PG, Lanier LL, Arase H.
    Cell; 2008 Mar 21; 132(6):935-44. PubMed ID: 18358807
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The amino terminus of herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like type-2 receptor alpha.
    Chowdhury S, Chouljenko VN, Naderi M, Kousoulas KG.
    J Virol; 2013 Mar 01; 87(6):3305-13. PubMed ID: 23302878
    [Abstract] [Full Text] [Related]

  • 52. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.
    Anderson DB, Laquerre S, Ghosh K, Ghosh HP, Goins WF, Cohen JB, Glorioso JC.
    J Virol; 2000 Mar 01; 74(5):2481-7. PubMed ID: 10666285
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y.
    Antiviral Res; 2017 Nov 01; 147():131-141. PubMed ID: 29061442
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Structural basis for the antibody neutralization of herpes simplex virus.
    Lee CC, Lin LL, Chan WE, Ko TP, Lai JS, Wang AH.
    Acta Crystallogr D Biol Crystallogr; 2013 Oct 01; 69(Pt 10):1935-45. PubMed ID: 24100313
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection.
    Tsvitov M, Frampton AR, Shah WA, Wendell SK, Ozuer A, Kapacee Z, Goins WF, Cohen JB, Glorioso JC.
    Virology; 2007 Apr 10; 360(2):477-91. PubMed ID: 17157347
    [Abstract] [Full Text] [Related]

  • 60. Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies.
    Tuzmen C, Cairns TM, Atanasiu D, Lou H, Saw WT, Hall BL, Cohen JB, Cohen GH, Glorioso JC.
    Mol Ther Methods Clin Dev; 2020 Mar 13; 16():145-154. PubMed ID: 32042851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.